An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WHO Guidelines for the Treatment of Chlamydia trachomatis.
Geneva: World Health Organization; 2016.
Top results in this bookTable of Contents
Cenegermin (Oxervate): CADTH Reimbursement Recommendation: Indication: For the treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
Guidelines on Recreational Water Quality: Volume 1 Coastal and Fresh Waters [Internet].
Geneva: World Health Organization; 2021.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Enfortumab Vedotin (Padcev): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with unresectable, locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and programmed death receptor-1 or programmed death-ligand 1 inhibitor therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jan.
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda [Internet].
Geneva: World Health Organization; 2022.
CADTH Canadian Drug Expert Committee Recommendation: Cysteamine Ophthalmic Solution (Cystadrops — Recordati Rare Diseases Canada Inc.): Indication: Treatment of corneal cystine crystal deposits (CCCDs) in adults and children from 2 years of age with cystinosis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun.
Prevention and Treatment of Mpox [Internet].
McLean JR, Zucker JE, Vail RM, et al.
Baltimore (MD): Johns Hopkins University; 2024 May.
Dupilumab (Dupixent): CADTH Reimbursement Recommendation: Indication: For the treatment of patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Oct.
Brolucizumab (Beovu): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Osimertinib (Tagrisso): CADTH Reimbursement Recommendation: Indication: As adjuvant therapy after tumour resection in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations [Internet].
Lyme disease: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2018 Oct 17. (NICE Guideline, No. 95.)
CADTH Canadian Drug Expert Committee Recommendation: Latanoprost (Monoprost — Laboratoires Théa): Indication: Glaucoma and Ocular Hypertension [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr.
WHO Guidelines for the Treatment of Neisseria gonorrhoeae.
2021 Guidelines: For the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 4th edition.
Cappellini MD, Farmakis D, Porter J, et al., editors.
Nicosia (Cyprus): Thalassaemia International Federation; 2023.
Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures.
CADTH Reimbursement Reviews and Recommendations.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013-.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on